- Home
- VABK vs KRRO Comparison
VABK vs KRRO Comparison
Compare VABK & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VABK
- KRRO
- Stock Information
- Founded
- VABK 1998
- KRRO 2014
- Country
- VABK United States
- KRRO United States
- Employees
- VABK N/A
- KRRO N/A
- Industry
- VABK Major Banks
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- VABK Finance
- KRRO Health Care
- Exchange
- VABK Nasdaq
- KRRO Nasdaq
- Market Cap
- VABK 197.3M
- KRRO 209.6M
- IPO Year
- VABK N/A
- KRRO 2019
- Fundamental
- Price
- VABK $36.90
- KRRO $10.80
- Analyst Decision
- VABK
- KRRO Strong Buy
- Analyst Count
- VABK 0
- KRRO 7
- Target Price
- VABK N/A
- KRRO $85.67
- AVG Volume (30 Days)
- VABK 4.0K
- KRRO 111.8K
- Earning Date
- VABK 07-18-2025
- KRRO 05-07-2025
- Dividend Yield
- VABK 3.88%
- KRRO N/A
- EPS Growth
- VABK 3.77
- KRRO N/A
- EPS
- VABK 3.30
- KRRO N/A
- Revenue
- VABK $54,953,000.00
- KRRO $4,821,000.00
- Revenue This Year
- VABK N/A
- KRRO $20.96
- Revenue Next Year
- VABK N/A
- KRRO N/A
- P/E Ratio
- VABK $11.32
- KRRO N/A
- Revenue Growth
- VABK 1.60
- KRRO N/A
- 52 Week Low
- VABK $28.71
- KRRO $10.29
- 52 Week High
- VABK $44.00
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- VABK 48.91
- KRRO 32.20
- Support Level
- VABK $36.83
- KRRO $14.54
- Resistance Level
- VABK $38.85
- KRRO $16.68
- Average True Range (ATR)
- VABK 0.84
- KRRO 1.48
- MACD
- VABK -0.13
- KRRO -0.37
- Stochastic Oscillator
- VABK 12.90
- KRRO 7.92
About VABK Virginia National Bankshares Corporation
Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.